Theranos Case | Elizabeth Holmes seeks a new trial for reversing the key witness

(New York) The founder of the start-up Theranos, which promised to revolutionize blood tests and was convicted of fraud, filed for a new trial on Tuesday, citing the reversal of a key witness.

Posted at 7:02pm

Elizabeth Holmes was found guilty by a federal jury in San Jose, California, in January and is due to announce her verdict on September 26 in the state.

She faces 20 years in prison for each of the four charges against her.

In a letter sent on Tuesday to federal judge Edward Davila, who presided over the 15-week trial between early September and late December 2021, Elizabeth Holmes’ attorneys say she received a visit from the former director of Theranos in early August. Labor, Adam Rosendorff.

The 38-year-old entrepreneur did not see the latter, but spoke to her companion William Evans, who passed the conversation on to the lawyers.

According to him, the researcher said he wanted to “honestly answer questions” asked during the trial, but prosecutors “were trying to paint everyone[Theranos alumni]in a bad light.”

“He said that during his hearing, the prosecution presented things more negatively than reality,” continued William Evans.

In particular, he disagreed with the notion that Elizabeth Holmes was deliberately trying to mislead investors about Theranos’ results and prospects.

“Everyone has worked hard to achieve something good and meaningful,” said Adam Rosendorff, Elizabeth Holmes’ companion. The doctor believes he “made a mistake” and says he wants to “help” his former boss.

For Elizabeth Holmes’ attorneys, Adam Rosendorff’s intervention warrants the holding of a new trial, particularly because he “made false testimony to the jury.”

Should the judge deny ordering a new trial based solely on these new elements, the defense will at a minimum request a new hearing of Adam Rosendorff to clarify the substance of his statements.

Elizabeth Holmes has become a symbol of the excesses of Silicon Valley culture.

She founded Theranos in 2003 when she was just 19 years old, promising diagnostic tools that were faster and cheaper than traditional labs.

Her charisma and confidence, as well as her rarity in a predominantly male-dominated world, had enabled her to lure celebrities and high-profile investors to the bedside of a company that would prove to be a house of cards that failed to produce conclusive results.

Leave a Comment